Search research articles
Contact Us
Filters
Showing results (271-280 of 296) with videos related to
Page
of 30
Sort By:
Clinicoeconomics and Outcomes Research : CEOR
|
July 23, 2013
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study
Urpo Kiiskinen, Stephan Matthaei, Matthew Reaney, et al.
FEBS Letters
|
December 9, 1998
An endogenous peptide isolated from the gut, NK-lysin, stimulates insulin secretion without changes in cytosolic free Ca2+ concentration
S V Zaitsev, M Andersson, A M Efanov, et al.
Molecular Diagnosis & Therapy
|
December 13, 2006
Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients
Barbara K Zehentner, Heather Secrist, XinQun Zhang, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 25, 2012
Bioportide: an emergent concept of bioactive cell-penetrating peptides
John Howl, Sabine Matou-Nasri, David C West, et al.
The Journal of Surgical Research
|
March 25, 2014
The effect of metallic tracheal stents on radiation dose in the airway and surrounding tissues
Andrew J Evans, David Y Lee, Anudh K Jain, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Different modes of action of the imidazoline compound RX871024 in pancreatic beta-cells. Blocking of K+ channels, mobilization of Ca2+ from endoplasmic reticulum, and interaction with exocytotic machinery
S V Zaitsev, A M Efanov, A Raap, et al.
BMC Medical Genetics
|
March 19, 2009
Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study
Ingrid Dahlman, Maria Nilsson, Harvest F Gu, et al.
Molecular Medicine (Cambridge, Mass.)
|
November 12, 2014
ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes
Michael Brines, Ann N Dunne, Monique van Velzen, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
December 12, 2001
Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat
Alexander M Efanov, Ioulia B Appelskog, Samy M Abdel-Halim, et al.
Endocrinology
|
June 1, 1996
Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats
A Höög, A C Sandberg-Nordqvist, S M Abdel-Halim, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 296) with videos related to
Sort By:
Page
of 30
Clinicoeconomics and Outcomes Research : CEOR
|
July 23, 2013
Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study
Urpo Kiiskinen, Stephan Matthaei, Matthew Reaney, et al.
FEBS Letters
|
December 9, 1998
An endogenous peptide isolated from the gut, NK-lysin, stimulates insulin secretion without changes in cytosolic free Ca2+ concentration
S V Zaitsev, M Andersson, A M Efanov, et al.
Molecular Diagnosis & Therapy
|
December 13, 2006
Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients
Barbara K Zehentner, Heather Secrist, XinQun Zhang, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 25, 2012
Bioportide: an emergent concept of bioactive cell-penetrating peptides
John Howl, Sabine Matou-Nasri, David C West, et al.
The Journal of Surgical Research
|
March 25, 2014
The effect of metallic tracheal stents on radiation dose in the airway and surrounding tissues
Andrew J Evans, David Y Lee, Anudh K Jain, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Different modes of action of the imidazoline compound RX871024 in pancreatic beta-cells. Blocking of K+ channels, mobilization of Ca2+ from endoplasmic reticulum, and interaction with exocytotic machinery
S V Zaitsev, A M Efanov, A Raap, et al.
BMC Medical Genetics
|
March 19, 2009
Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study
Ingrid Dahlman, Maria Nilsson, Harvest F Gu, et al.
Molecular Medicine (Cambridge, Mass.)
|
November 12, 2014
ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes
Michael Brines, Ann N Dunne, Monique van Velzen, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
December 12, 2001
Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat
Alexander M Efanov, Ioulia B Appelskog, Samy M Abdel-Halim, et al.
Endocrinology
|
June 1, 1996
Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats
A Höög, A C Sandberg-Nordqvist, S M Abdel-Halim, et al.
Page
of 30